Viewing Study NCT02300935

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:32 PM
Ignite Modification Date: 2026-02-25 @ 4:13 AM
Study NCT ID: NCT02300935
Status: WITHDRAWN
Last Update Posted: 2019-05-30
First Post: 2014-11-21
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Trametinib and Nab-paclitaxel in Patients With Melanoma
Sponsor: SCRI Development Innovations, LLC
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None trametinib View
None nab-paclitaxel View
None Mekinist View
None Abraxane View
None unresectable View
None metastatic View